Savior Lifetec Corporation (TPEX:4167)
Taiwan · Delayed Price · Currency is TWD 19.70
+0.50 (2.60%)
May 29, 2026, 1:30 PM CST
Savior Lifetec Market Cap
Savior Lifetec has a market cap or net worth of 6.12 billion as of May 29, 2026. Its market cap has decreased by -0.68% in one year.
Market Cap
6.12B
Enterprise Value
4.67B
Revenue
1.17B
Ranking
n/a
PE Ratio
25.37
Stock Price
19.70
Market Cap Chart
Since December 21, 2012, Savior Lifetec's market cap has increased from 3.75B to 6.12B, an increase of 63.08%. That is a compound annual growth rate of 3.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 6.12B | 7.07% |
| Dec 31, 2025 | 5.71B | -11.78% |
| Dec 31, 2024 | 6.47B | -9.13% |
| Dec 29, 2023 | 7.13B | -9.37% |
| Dec 30, 2022 | 7.86B | 29.94% |
| Dec 30, 2021 | 6.05B | -41.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEngine | 7.70B |
| Adimmune | 7.23B |
| Acepodia | 7.13B |
| TaiGen Biopharmaceuticals Holdings | 6.45B |
| Sinphar Pharmaceutical | 5.84B |
| Mycenax Biotech | 5.63B |
| AnnJi Pharmaceutical | 5.52B |
| ACRO Biomedical | 5.31B |